Literature DB >> 31858302

Continuous monitoring of changes in cerebral oxygenation during hemodialysis in a patient with acute congestive heart failure.

Saori Minato1, Susumu Ookawara1, Kiyonori Ito2, Hideyuki Hayasaka3, Masaya Kofuji3, Takayuki Uchida3, Mitsutoshi Shindo1, Haruhisa Miyazawa1, Hirofumi Shimoyama1,4, Taro Hoshino5, Yoshiyuki Morishita1.   

Abstract

A 71-year-old man undergoing hemodialysis (HD) was admitted to our hospital with congestive heart failure (CHF) and pneumonia. After admission, ultrafiltration with HD was urgently performed because of a lack of respiratory improvement despite the use of noninvasive positive pressure ventilation. During HD, cerebral regional saturation of oxygen (rSO2) was monitored by INVOS 5100c oxygen saturation monitor (Covidien Japan, Japan) to evaluate changes in tissue oxygenation. At HD initiation, cerebral rSO2 was very low at 34% under the fraction of inspiratory oxygen (FiO2) of 0.4. Ultrafiltration was performed at the rate of 0.5 L/h thereafter, cerebral rSO2 gradually improved even as inhaling oxygen concentration decreased. At the end of HD, cerebral rSO2 improved at 40% under a FiO2 of 0.28 as excess body fluid was removed. After pneumonia and CHF improved, he was discharged. Reports of the association between cerebral oxygenation and acute CHF status in patients undergoing HD are limited; therefore, in our experience with this case, cerebral oxygenation deteriorated with the CHF status but was improved by adequate body-fluid management during HD.

Entities:  

Keywords:  Acute heart failure; Cerebral oxygenation; Hemodialysis; Regional saturation of oxygen; Ultrafiltration

Year:  2019        PMID: 31858302     DOI: 10.1007/s10047-019-01150-2

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  1 in total

1.  Difference in Cerebral and Hepatic Oxygenation in Response to Ultrafiltration in a Hemodialysis Patient With Congestive Heart Failure.

Authors:  Yuko Mutsuyoshi; Kiyonori Ito; Susumu Ookawara; Takayuki Uchida; Yoshiyuki Morishita
Journal:  Cureus       Date:  2021-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.